Table 2.

Baseline characteristics of patients in the lanreotide group with vs. without hepatic cyst infection

Characteristics	Hepatic cyst infection (n = 7)		Missing (n)	No hepatic cyst infection (n = 147)		Missing (n)	p value
Female, n (%)	5	(71)	0	77	(52)	0	0.32
Age, years [IQR]	53	[48–55]	0	49	[43–54]	0	0.24
BMI, kg/m2 [IQR]	26	[24–26]	0	26	[24–29]	0	0.19
Serum
Creatinine, µmol/L [IQR]	128	[104–131]	0	130	[109–153]	0	0.51
eGFR, mL/min/1.73 m2 [IQR]	42	[41–58]	0	50	[40–59]	0	0.97
AST, U/L [IQR]	25	[21–29]	0	23	[19–27]	0	0.50
ALT, U/L [IQR]	28	[25–30]	0	23	[18–29]	0	0.12
ALP, U/L [IQR]	66	[49–84]	0	67	[56–80]	3	0.90
GGT, U/L [IQR]	47	[22–105]	0	33	[24–48]	0	0.20
Bilirubin direct, µmol/L [IQR]	5	[3–5]	3	4	[3–5]	37	0.40
Bilirubin indirect, µmol/L [IQR]	6	[1–14]	2	6	[4–8]	30	0.88
Volume
hTLV, mL/m [IQR]	1901	[997–2723]	0	1218	[993–1667]	3	0.17
hTKV, mL/m [IQR]	1093	[529–1893]	0	1150	[798–1658]	4	0.57
TLV > 2000 mL, n (%)	5	(71)	0	87	(60)	3	0.56
Medical history, n (%)
Hepatic cyst infection	2	(29)	0	1	(0.7)	0	<0.001
Renal cyst infection	1	(14)	0	13	(9)	0	0.63
Urinary tract infection	3	(43)	0	74	(50)	0	0.70

Data are expressed as mean ± standard deviation, percentage, or median with IQR

ALT alanine aminotransferase, ALP alkaline phosphatase, AST aspartate aminotransferase, BMI body mass index, eGFR estimated glomular filtration rate average baseline and screening, hTLV height-adjusted total liver volume, hTKV height-adjusted total kidney volume, GGT gamma-glutamyl transferase, IQR interquartile range, TLV total liver volume